Probable interaction ID'd for PrOD, ribavirin with warfarin

November 8, 2016

(HealthDay)—There is a probable interaction between paritaprevir/ritonavir/ombitasvir+dasabuvir (PrOD) plus ribavirin with warfarin, according to a case report published online Nov. 3 in the Journal of Clinical Pharmacy and Therapeutics.

Gina M. Puglisi, Pharm.D., from VA Maine Healthcare System in Augusta, and colleagues present the case of a probable interaction between PrOD with ribavirin and warfarin in a 58-year-old with hepatitis C virus genotype 1a, who was treatment naive. The patient took outpatient medications, including warfarin for stroke risk reduction. The patient was initiated on PrOD with ribavirin for 12 weeks for hepatitis treatment.

The authors note that the patient's international normalized ratio (INR) became subtherapeutic two weeks after the start of PrOD with ribavirin. Therapeutic INR was achieved 11 weeks into and following a 125 percent total increase in the weekly warfarin dose. The patient's INR became critically supratherapeutic 13 days after completion of direct-acting antiviral therapy was completed and discontinued. A score of +7 was obtained using the Naranjo Nomogram, which indicated that the increase in INR for warfarin produced by PrOD with ribavirin was probable.

"Patients on PrOD plus with warfarin should have INR followed closely upon initiation and discontinuation of therapy due to a probable drug interaction," the authors write.

Explore further: One-third of patients don't retain important warfarin info

More information: Full Text (subscription or payment may be required)

Related Stories

One-third of patients don't retain important warfarin info

August 15, 2016

(HealthDay)—Just over two-thirds of patients retain an "acceptable" amount of key information following warfarin counseling, according to a small study published online Aug. 6 in the Journal of Pharmacy Practice and Research.

Carbamazepine affects warfarin anticoagulation

January 29, 2016

(HealthDay)—For warfarin-treated patients, carbamazepine co-treatment is associated with subtherapeutic anticoagulative effect and increased warfarin dose requirements, according to a study published online Jan. 21 in the ...

Patient satisfaction up with pharmacist-managed warfarin Tx

October 4, 2016

(HealthDay)—Pharmacist-managed warfarin anticoagulation therapy is associated with improved patient satisfaction, although the benefits in terms of control, safety, and mortality are unclear, according to a review published ...

Physician-perceived frailty tied to warfarin discontinuation

August 17, 2016

(HealthDay)—Physician-perceived frailty and low life expectancy are the main reasons for warfarin discontinuation in elderly patients, according to a study published online July 29 in the Journal of Thrombosis and Haemostasis.

Most patients prefer oral dual therapy in chronic hepatitis C

September 20, 2016

(HealthDay)—For patients with chronic hepatitis C (CHC), most prefer oral therapy with sofosbuvir (SOF) and ribavirin (RBV) versus triple therapy involving pegylated interferon (PegIFN), according to a study published online ...

Recommended for you

Nigeria: Clean-burning stoves improve health for new mothers

January 13, 2017

In a small clinical trial that replaced widely used biomass and kerosene cookstoves with clean-burning ethanol stoves, a team of researchers from the University of Chicago and the University of Ibadan (Nigeria) was able to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.